Ask AI
ProCE Banner Series

Moving the Needle: Leveraging Emerging Strategies for Better Endometrial Cancer Care

This live, 1-hour virtual roundtable will feature a conversation on emerging novel therapies for endometrial cancer care, including antibody–drug conjugates and targeted therapies. The program will explore recent clinical trial results and emerging treatments with discussions focusing on strategies for integrating these advancements into clinical practice.

  AMA
Who Should Attend

This educational activity is intended for medical oncologists and other healthcare professionals who care for patients with endometrial cancer. 

All Events

Moving the Needle: Leveraging Emerging Strategies for Better Endometrial Cancer Care

Upcoming Events

November

19

2025

12:00 PM - 1:00 PM Eastern Time (ET)

Virtual

Topics

Gynecologic Cancer

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners' knowledge, confidence, and competence at integrating novel therapies into the care of patients with advanced endometrial cancer progressing after standard frontline immunotherapy plus chemotherapy.

Target Audience
This educational activity is intended for medical oncologists and other healthcare professionals who care for patients with endometrial cancer. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Analyze current recommendations for molecular testing in endometrial cancer, including the rationale, patient counseling approaches, optimal test ordering strategies, and clinical implications of key biomarkers.

  • Compare and contrast the efficacy, safety, and appropriate patient selection criteria for available and emerging immune checkpoint inhibitor-based and targeted therapies in endometrial cancer management.

  • Analyze the latest clinical data on emerging antibody-drug conjugates (ADCs) for advanced endometrial cancer, examining their mechanisms of action, efficacy, safety profiles, and potential impact on treatment strategies.

  • Examine key factors contributing to care disparities in endometrial cancer patients, with a focus on Black, transgender, and underserved populations, and critically evaluate strategies to address these disparities in clinical practice.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/67167f3d10da3.png

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through CCO's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.com  to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC

Supporters

Supported by educational grants from Eisai, Gilead Sciences, Inc., and Merck Sharp & Dohme LLC.

Eisai

Gilead Sciences, Inc.

Merck Sharp & Dohme, LLC

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191